STOCK TITAN

Clarivate launches $75M tender for 2028 notes

Clarivate Plc (CLVT) announced that its wholly owned subsidiary, Clarivate Science Holdings Corporation, has commenced a cash tender offer for a portion of its 3.875% Senior Secured Notes due 2028.

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Clarivate Plc (CLVT) announced that its wholly owned subsidiary, Clarivate Science Holdings Corporation, has commenced a cash tender offer for a portion of its 3.875% Senior Secured Notes due 2028. The offer is capped at $75,000,000 aggregate principal amount of notes, subject to proration and other terms in the Offer to Purchase.

The notes have $825,000,000 aggregate principal amount outstanding, with a maturity date of July 1, 2028. The Total Consideration per $1,000 principal will be based on a fixed spread of 50 basis points over the yield of the 4.125% U.S. Treasury due June 30, 2028, determined on September 23, 2026. The offer is scheduled to expire at 5:00 p.m. New York City time on September 23, 2026, with settlement expected on September 25, 2026, and includes payment of accrued and unpaid interest on accepted notes.

Positive

  • None.

Negative

  • None.

Filing Explained

The subsidiary has launched the debt tender offer, but no notes are reported as accepted or purchased; any debt reduction remains conditional, capped at $75,000,000, and not yet completed.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Tender Cap $75,000,000 principal amount Maximum aggregate principal amount of notes to be purchased in the offer
Aggregate Principal Amount Outstanding $825,000,000 Total principal of 3.875% Senior Secured Notes due 2028 outstanding
Coupon Rate 3.875% Interest rate on Senior Secured Notes due 2028 targeted by the offer
Maturity Date of Notes July 1, 2028 Scheduled maturity of 3.875% Senior Secured Notes
Fixed Spread 50 basis points Spread over Reference Security yield to determine Total Consideration
Reference Security Coupon and Maturity 4.125% UST due June 30, 2028 Treasury security used to determine Reference Yield
Offer Expiration 5:00 p.m. New York City time on September 23, 2026 Scheduled expiration date and time of the tender offer
Expected Settlement Date September 25, 2026 Second business day after expiration date for settlement of accepted tenders
cash tender offer financial
"has commenced a cash tender offer (the "Offer") to purchase the outstanding notes"
A cash tender offer is a public proposal in which an individual or group offers to buy a set number of a company's shares directly from shareholders for a specified cash price during a limited time. It matters to investors because it gives a clear, immediate chance to sell shares at a known price — like a store offering to buy back items at a posted rate — and can affect the stock’s market price, ownership control and liquidity.
Total Consideration financial
"The "Total Consideration" payable per each $1,000 principal amount of Notes"
Total consideration is the full amount of value exchanged in a transaction, including all payments, assets, or benefits involved. It represents what is given up or received in a deal, much like the total price paid when buying a house, covering both the purchase price and any additional costs or benefits. For investors, understanding total consideration helps assess the true scale and value of a transaction.
Reference Security financial
"Reference Security as quoted on the Bloomberg Reference Page"
A reference security is a specific financial asset, such as a bond or stock, used as a standard for measuring or comparing the value of other related investments. It acts like a benchmark or point of reference, helping investors assess how well other assets are performing relative to a known standard. This makes it easier to understand the value and risk of different investments in relation to one another.
Fixed Spread financial
"based on the Fixed Spread, plus the Reference Yield"
A fixed spread is a set difference between the buying and selling prices of a financial instrument that remains constant regardless of market conditions. For investors, this means the cost to trade stays predictable, making it easier to understand potential expenses and plan accordingly—similar to a fixed fee in a service that doesn’t change, no matter how busy or slow the market becomes.
Settlement Date financial
"The "Settlement Date" will be the second business day after the Expiration Date"
The settlement date is the day when a securities trade is finalized: the buyer’s cash is delivered and the seller’s shares or bonds are transferred into the buyer’s account. Think of it like the closing day of a purchase, when ownership and payment officially change hands; until then the trade exists as an agreement but not as completed property transfer. Investors care because payment timing affects cash availability, record of ownership, dividends, and legal rights tied to the asset.
Tender Cap financial
"subject to a $75,000,000 cap on the aggregate principal amount of Notes"
A tender cap is the maximum number of shares or maximum total value a buyer will accept in a tender offer, essentially a limit on how much stock the bidder is willing to buy. It matters to investors because if more shares are tendered than the cap allows, the buyer will scale back purchases proportionally, like selling a fixed number of tickets when demand is higher than supply, which affects how many shares each holder can sell and the likely outcome of the offer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What debt securities is CLVT targeting in this tender offer?

Clarivate’s subsidiary is offering to purchase its 3.875% Senior Secured Notes due 2028. These notes have an aggregate principal amount outstanding of $825,000,000 and mature on July 1, 2028.

How large is Clarivate (CLVT)’s note tender offer?

The tender offer is subject to a $75,000,000 Tender Cap on the aggregate principal amount of notes that may be purchased. The company may eliminate, increase or decrease the Tender Cap before the expiration date, subject to applicable law.

When does Clarivate (CLVT)’s tender offer expire and settle?

The offer is scheduled to expire at 5:00 p.m. New York City time on September 23, 2026. The expected Settlement Date is September 25, 2026, the second business day after the expiration date.

How will the Total Consideration be determined in CLVT’s tender offer?

The Total Consideration per $1,000 principal will be based on a 50 basis point fixed spread over the Reference Yield of the 4.125% U.S. Treasury due June 30, 2028, as quoted at 2:00 p.m. New York City time on September 23, 2026.

Can holders withdraw tendered notes in Clarivate (CLVT)’s offer?

Yes. Tenders of notes may be validly withdrawn at any time at or prior to 5:00 p.m. New York City time on September 23, 2026. After that time, withdrawals are generally not permitted except as described in the Offer to Purchase or as required by law.

Who is managing Clarivate (CLVT)’s tender offer process?

Clarivate’s subsidiary has retained Citigroup Global Markets Inc. as the dealer manager for the offer, and Global Bondholder Services Corporation as the Tender and Information Agent to handle documents and tendering questions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001764046 0001764046 2026-09-17 2026-09-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): September 17, 2026

 

CLARIVATE PLC

(Exact name of registrant as specified in its charter)

 

Jersey, Channel Islands

(State or other jurisdiction of incorporation or organization)

 

001-38911

(Commission File Number)

 

N/A

(I.R.S. Employer Identification No.)

 

70 St. Mary Axe

London EC3A 8BE

United Kingdom

(Address of Principal Executive Offices)

 

(44) 207-433-4000

Registrant's telephone number, including area code

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Ordinary Shares, no par value CLVT New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

Item 8.01. Other Events.

 

On September 17, 2026, Clarivate Plc issued a press release announcing the launch of cash tender offer by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, for certain of its debt securities. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

No. Description
99.1 Press release issued by Clarivate Plc dated September 17, 2026
104 Cover page of this Current Report on Form 8-K formatted in Inline XBRL

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  CLARIVATE PLC
   
Date: September 17, 2026 By: /s/ John Doulamis
  Name: John Doulamis
  Title: Senior Vice President, General Counsel

 

 

Exhibit 99.1

 

Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

 

LONDON, September 17, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the “Company”), has commenced a cash tender offer (the "Offer") to purchase the outstanding notes described below, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 17, 2026 (the "Offer to Purchase").

 

The Company is offering to purchase in the Offer its 3.875% Senior Secured Notes due 2028 (the “Notes”) for the consideration described below, subject to a $75,000,000 cap on the aggregate principal amount of Notes purchased in the Offer (the "Tender Cap") subject to proration and the terms and conditions set forth in the Offer to Purchase. Subject to applicable law, the Company may, but is under no obligation to, eliminate, increase or decrease the Tender Cap at any time prior to the Expiration Date. In the event proration is required with respect to the Notes, the Company will multiply the principal amount of each valid tender of such Notes by the proration rate and round the resulting amount down to the nearest $1,000 principal amount in order to determine the principal amount of such tender that will be accepted pursuant to the Offer. The excess principal amount of Notes not accepted from the tendering Holders will be promptly returned to such Holders, and if this excess principal amount of Notes is less than $2,000, the Company may either accept or reject all such tendering Holders' validly tendered Notes in its sole discretion. Additionally, the Company may increase the amount of Notes accepted for payment in the Offer by no more than 2% of the outstanding Notes without amending or extending the Offer, and may also increase or decrease the percentage of the Notes accepted for payment in the Offer (including by more than 2% of the outstanding Notes) by a press release or other public announcement that is widely disseminated by Clarivate by no later than 9:00 a.m. (New York City time), on the third business day before the scheduled Expiration Date. Capitalized terms used but not defined in this press release have the meanings given to them in the Offer to Purchase.

 

Notes Issuer CUSIP / ISIN Number(1) Aggregate Principal Amount Outstanding Maturity Date Reference Security Bloomberg Reference Page Fixed Spread (Basis Points)
3.875% Senior Secured Notes due 2028 Clarivate Science Holdings Corporation

144A: 18064P AC3 / US18064PAC32

 

Reg S: U1800Q AC3 / USU1800QAC34

$825,000,000 July 1, 2028 4.125% UST due June 30, 2028 FIT 4 +50

 

 

(1)       No representation is made as to the correctness or accuracy of the CUSIP or ISIN numbers listed above.

 

The "Total Consideration" payable per each $1,000 principal amount of Notes validly tendered for purchase will be based on the Fixed Spread, plus the Reference Yield based on the Reference Security as quoted on the Bloomberg Reference Page as of 2:00 p.m., New York City time, on September 23, 2026, unless extended by the Company with respect to the Offer (such date and time, as the same may be extended by the Company with respect to the Offer, the "Price Determination Date"). Unless extended, promptly after the Price Determination Date, Clarivate will announce in a press release, among other things, the Total Consideration. In addition to the Total Consideration, Holders whose Notes are accepted for purchase pursuant to the Offer will receive accrued and unpaid interest on those Notes from the last interest payment date with respect to those Notes to, but excluding, the Settlement Date (the "Accrued Interest," and the payment thereof, the "Accrued Coupon Payment").

 

The Offer is scheduled to expire on the Expiration Date, which is 5:00 p.m., New York City time, on September 23, 2026, unless extended or earlier terminated by the Company. Tenders of Notes may be validly withdrawn at any time at or prior to 5:00 p.m., New York City time, on September 23, 2026, but, except as provided in the Offer to Purchase or required by applicable law, may not be validly withdrawn thereafter.

 

The "Settlement Date" will be the second business day after the Expiration Date and is expected to be September 25, 2026.

 

The Offer is subject to certain conditions as described in the Offer to Purchase. If any condition is not satisfied, the Company is not obligated to accept for payment, purchase or pay for, and may delay the acceptance for payment of, any tendered Notes, in each case subject to applicable law, and may terminate or alter the Offer. The Offer is not contingent upon the tender of any aggregate minimum principal amount of Notes (subject to minimum denomination requirements as set forth in the Offer to Purchase).

 

The Company has retained Citigroup Global Markets Inc. to act as dealer manager (the "Dealer Manager") for the Offer. Global Bondholder Services Corporation will act as the Tender and Information Agent for the Offer. For additional information, please contact: Citigroup Global Markets Inc. at +1 (800) 558-3745 (toll-free) or +1 (212) 723-6106 (collect). Requests for documents and questions regarding the tendering of Notes may be directed to Global Bondholder Services Corporation by telephone at (212) 430-3774 (for banks and brokers only) and (855) 654-2015 (for all others toll-free) or to the Dealer Manager at its telephone number. Copies of the Offer to Purchase are available at: https://www.gbsc-usa.com/clarivate/. You may also contact your broker, dealer, commercial bank, trust company or other nominee for assistance concerning the Offer.

 

Holders of Notes are advised to check with each bank, securities broker or other intermediary through which they hold Notes as to when such intermediary would need to receive instructions from a beneficial owner in order for that Holder to be able to participate in, or withdraw their instruction to participate in the Offer before the deadlines specified herein and in the Offer to Purchase. The deadlines set by any such intermediary and DTC for the submission and withdrawal of tender instructions may be earlier than the relevant deadlines specified herein and in the Offer to Purchase.

 

 

 

This press release is neither an offer to purchase nor a solicitation of an offer to sell the Notes or any other securities. The Offer is made only by and pursuant to the terms of the Offer to Purchase and only to such persons and in such jurisdictions as is permitted under applicable law. The information in this press release is qualified by reference to the Offer to Purchase. None of the Company, Clarivate, the Dealer Manager or the Tender and Information Agent makes any recommendation as to whether Holders should tender their Notes pursuant to the Offer. Holders must make their own decisions as to whether to tender Notes, and, if so, the principal amount of Notes to tender.

 

Forward-Looking Statements

 

This release includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements” within the meaning of the “safe harbor provisions” of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include all matters that are not historical facts, including statements relating to our intentions, beliefs, or current expectations concerning, among other things, the completion of the Offer. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will,” or “should” or, in each case, their negative or other variations or comparable terminology. Such forward-looking statements are based on available current market material and management’s expectations, beliefs, and forecasts concerning future events impacting us. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in Item 1A. Risk Factors in our annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission (“SEC”). There can be no assurance that future developments affecting us will be those that we have anticipated. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Please consult our public filings with the SEC, which are also available on our website at www.clarivate.com.

 

About Clarivate

 

Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property, and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.

 

Media Contact:

Amy Bourke-Waite, Senior Director, Communications & Brand

newsroom@clarivate.com

 

Investor Relations Contact:

Mark Donohue, Vice President, Investor Relations

investor.relations@clarivate.com

 

 

Filing Exhibits & Attachments

4 documents

Keep reading